本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

2.30
-0.1800-7.26%
盘后:2.350.0499+2.17%17:24 EDT
成交量:389.13万
成交额:903.91万
市值:2.52亿
市盈率:-13.53
高:2.55
开:2.47
低:2.26
收:2.48
52周最高:5.45
52周最低:2.26
股本:1.10亿
流通股本:8,539.15万
量比:1.42
换手率:4.56%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
净资产收益率:-4.77%
总资产收益率:-28.42%
市净率:0.68
市盈率(LYR):-1.14

数据加载中...

2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

重要事件披露

Form 8-K - Current report
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities